Phacilitate Leaders Forum

17th - 18th SEPTEMBER 2019

ROYAL LANCASTER LONDON

Speakers

Loading
Ajan Reginald

Ajan Reginald

CEO, Celixir Plc

Co-Founder and Chief Executive of Cell Therapy Ltd - the innovative regenerative medicine company  that he founded with Nobel Laureate, Professor Martin Evans.

Cell Therapy invents and develops Regenerative Medicines for Life™ - breakthrough cellular medicines that treat life threatening / life changing diseases. In 2014, Cell Therapy completed Phase II clinical trials in End-stage heart failure with Phase III trials starting in 2015. The company’s pipeline also includes consists of 2 more disease specific products in Phase II trials for Orthopaedic and Dermatology indications.

Ajan is an inventor of CTL’s core technology and tissue specific regenerative medicine products and leads the company’s commercial and operational activities.

Ajan was Roche’s Global Head of Emerging Technologies overseeing the identification, acquisition and development of the next generation of breakthrough Biopharma technologies and products. He joined Roche as Business Development Director in Roche Pharma, where he led M&A teams and major licensing transactions including the $1.3B licensing transaction with Alnylam.

Prior to Roche, Ajan was a consultant with the Boston Consulting Group and received a MBA from Kellogg Business School, Northwestern University where he was awarded the Biotechnology scholarship. In 2002, he was awarded the UK Fulbright Scholarship.

Testimonials
  • Real thinking forward combining experts in the field from manufacturing, regulatory and value vision” – “great network with strong experience and sharing risks & opportunities
    Jean-Philippe Combal
    GenSight Biologics
  • The conference consistently proves to be a great forum for networking with industry leaders in the development of cellular and gene therapies as well as vendors for important technologies and services.
    Michael Covington
    Juno Therapeutics, Inc
  • It was a very interesting event as all participants, including speakers were ready to exchange, even on the most challenging subjects such as reimbursement, GMP guidance
    Bertrand Alexandre
    Celyad
  • Phacilitate EU delivered it's promise and more, the topics discussed were highly relevant, with very good and professional speakers and panelists. You will see me next year in Berlin.
    Dr Ohad Karnieli
    Karnieli Ltd